Frederic Dumais - ChitogenX Director Relations

CHNXF Stock  USD 0.01  0.0001  2.00%   

Director

Frederic Dumais is Director Relations of ChitogenX
Phone514-782-0951
Webhttps://www.chitogenx.com

ChitogenX Management Efficiency

The company has return on total asset (ROA) of (2.9216) % which means that it has lost $2.9216 on every $100 spent on assets. This is way below average. ChitogenX's management efficiency ratios could be used to measure how well ChitogenX manages its routine affairs as well as how well it operates its assets and liabilities.
ChitogenX has accumulated 4.78 M in total debt. ChitogenX has a current ratio of 1.23, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist ChitogenX until it has trouble settling it off, either with new capital or with free cash flow. So, ChitogenX's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ChitogenX sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ChitogenX to invest in growth at high rates of return. When we think about ChitogenX's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

DIRECTOR Age

Frederic MDImmutep Ltd ADR
69
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada. Chitogenx is traded on OTC Exchange in the United States. ChitogenX [CHNXF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

ChitogenX Leadership Team

Elected by the shareholders, the ChitogenX's board of directors comprises two types of representatives: ChitogenX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ChitogenX. The board's role is to monitor ChitogenX's management team and ensure that shareholders' interests are well served. ChitogenX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ChitogenX's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jonathan Sackier, Chief Officer
Benedek Simo, Controller
MBA MBA, VP CFO
GuyPaul Allard, VP Sec
Philippe Deschamps, Pres CEO
Frederic Dumais, Director Relations

ChitogenX Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is ChitogenX a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in ChitogenX OTC Stock

ChitogenX financial ratios help investors to determine whether ChitogenX OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChitogenX with respect to the benefits of owning ChitogenX security.